Navigation Links
Onyx Pharmaceuticals Reports 2008 First Quarter Results
Date:5/6/2008

of March 31, 2008, the company had cash, cash equivalents, and short and long-term marketable securities of $456.6 million compared to $469.7 million at December 31, 2007. This decrease was primarily due to cash used in operations for the three months ended March 31, 2008.

Conference Call with Management Today

Onyx's management will host a teleconference and webcast to provide an update on Nexavar and discuss first quarter 2008 financial results. The event will begin at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on May 6, 2008. Interested parties may access a live webcast of the presentation on our website at:

http://www.onyx-pharm.com/wt/page/event_calendar

or by dialing 630-691-2760 and using the passcode 21488196. A replay of the presentation will be available on the Onyx website or by dialing 630-652-3044 and using the passcode 21488196 approximately one hour after the teleconference concludes. The replay will be available through June 6, 2008.

About Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer by changing the way cancer is treated(TM). The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developing and marketing Nexavar(R) (sorafenib) tablets, a small molecule drug. Nexavar is currently approved for the treatment of liver cancer and advanced kidney cancer. Additionally, Nexavar is being investigated in several ongoing trials in non-small cell lung cancer, melanoma, breast cancer and other cancers. For more information about Onyx, visit the company's website at: http://www.onyx-pharm.com.

Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.

This news release contains "forward-looking statements" of Onyx within
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014. Applied DNA Sciences, ... provides DNA-based authentication and security solutions and services, has ... Life Sciences, a newly created position, with a starting ... lead APDN’s drive to build its business in pharmaceuticals ... customers, provide guidance to APDN’s R&D efforts, and apply ...
(Date:7/30/2014)...  Orexigen Therapeutics, Inc. (Nasdaq: OREX ) ... of Outstanding Issues (LOI) from the European Medicines Agency,s ... the NB32 Marketing Authorization Application (MAA). NB32 (naltrexone sustained ... candidate being evaluated for weight loss. The ... were adequately addressed by the Company based in part ...
(Date:7/30/2014)... , July 30, 2014  AtheroNova Inc. (OTCBB: ... and development of compounds to safely regress atherosclerotic ... announces that its partner, CardioNova, has accomplished first ... trial with AtheroNova,s lead compound, AHRO-001.  This Phase ... AHRO-001 Phase 1 safety trial completed in February ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Vala ... the U.S. Environmental Protection Agency (EPA). This new ... developmental toxicity models, including tests designed to assess ... and the formation of connections between neurons (synapses), ... neurodifferentiation and synapse formation by environmental pollutants likely ...
Breaking Biology Technology:Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 2Dr. Michael E. Hogan, Ph.D., Joins Applied DNA Sciences as Vice President, Life Sciences 3Orexigen Receives CHMP Day 180 List of Outstanding Issues 2Orexigen Receives CHMP Day 180 List of Outstanding Issues 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 2U.S. Environmental Protection Agency (EPA) Awards Vala Sciences a Second ToxCast Contract 3
... - GeneNews Limited (TSX: GEN),a company focused on ... sample for the early detection of diseases and ... System,which covers the design and development of in-vitro ... colorectal disease status in a laboratory,setting, has met ...
... provider of,ion channel testing services for drug discovery ... expanding line of services in booth 2504 at,the ... Washington.,New FDA Critical Path safety profiling tools include ... ChanTest designed to,complement the FDA and ICH S7A ...
... Beckman Coulter,Inc. (NYSE: BEC ), a leading ... and innovate complex biomedical testing,announced today that Paul ... Business Development, will present at the 2008 Bear ... at 4:00 a.m.,(ET)., (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ), ...
Cached Biology Technology:GeneNews receives ISO 13485 accreditation 2ChanTest to Highlight Expanded Ion Channel Testing Services for Preclinical Safety at ToxExpo, Including the World's Largest Catalog of Validated Ion Channels, Booth 2504 2Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference 2
(Date:7/30/2014)... Entomological Society of America (ESA) has elected ten new ... a Fellow acknowledges outstanding contributions to entomology in one ... administration. The following Fellows will be recognized during Entomology ... be held November 16-19, 2014 in Portland, Oregon. , ... with the Department of Plant, Soil and Entomological Sciences ...
(Date:7/30/2014)... -- A study of dominance in female baboons suggests that ... ties with mom, and to have lots of supportive sisters. ... size or strength, but by the rank of her mother ... daughter will be. For this reason, dominance rank in female ... to high-ranking mothers are guaranteed a good spot in the ...
(Date:7/30/2014)... New York , July 30, 2014 /PRNewswire/ ... research on Global Government Biometric Systems Market ... The Global Biometric Systems Market 2014-2024" ... biometric systems market over the next ten years, ... using detailed market size forecasts. To ...
Breaking Biology News(10 mins):Entomological Society of America recognizes 2014 fellows 2Entomological Society of America recognizes 2014 fellows 3Entomological Society of America recognizes 2014 fellows 4Entomological Society of America recognizes 2014 fellows 5Entomological Society of America recognizes 2014 fellows 6Entomological Society of America recognizes 2014 fellows 7Entomological Society of America recognizes 2014 fellows 8Entomological Society of America recognizes 2014 fellows 9Entomological Society of America recognizes 2014 fellows 10Entomological Society of America recognizes 2014 fellows 11Entomological Society of America recognizes 2014 fellows 12Entomological Society of America recognizes 2014 fellows 13Entomological Society of America recognizes 2014 fellows 14Entomological Society of America recognizes 2014 fellows 15Entomological Society of America recognizes 2014 fellows 16Entomological Society of America recognizes 2014 fellows 17Supportive moms and sisters boost female baboon's rank 2Supportive moms and sisters boost female baboon's rank 3Global Government Biometric Systems Market Size, Share, Trends and Forecasts 2014-2024 Available Online by Researchmoz.us 2Global Government Biometric Systems Market Size, Share, Trends and Forecasts 2014-2024 Available Online by Researchmoz.us 3Global Government Biometric Systems Market Size, Share, Trends and Forecasts 2014-2024 Available Online by Researchmoz.us 4Global Government Biometric Systems Market Size, Share, Trends and Forecasts 2014-2024 Available Online by Researchmoz.us 5Global Government Biometric Systems Market Size, Share, Trends and Forecasts 2014-2024 Available Online by Researchmoz.us 6Global Government Biometric Systems Market Size, Share, Trends and Forecasts 2014-2024 Available Online by Researchmoz.us 7Global Government Biometric Systems Market Size, Share, Trends and Forecasts 2014-2024 Available Online by Researchmoz.us 8Global Government Biometric Systems Market Size, Share, Trends and Forecasts 2014-2024 Available Online by Researchmoz.us 9Global Government Biometric Systems Market Size, Share, Trends and Forecasts 2014-2024 Available Online by Researchmoz.us 10
... have called for the guidance documents for the implementation ... updated. The consensus among the scientists and stakeholders who ... for Environmental Research (UFZ) in November was that the ... be taken further. The experts can already see that ...
... NC Scientists at Duke University have created the first ... say a modern-day Rosetta stone a form of artificial ... success. The study revealed four times as many ... on the cover of the December 3 issue of Genome ...
... 8 million people at high risk for advanced age-related ... the experimental drug, endostatin, may be the cure. A ... The FASEB Journal, describes how giving endostatin to mice ... the eye, which is ultimately why the disease causes ...
Cached Biology News:Further development of Water Framework Directive necessary 2Further development of Water Framework Directive necessary 3Duke scientists map imprinted genes in human genome 2Duke scientists map imprinted genes in human genome 3New treatment for age-related macular degeneration within sight 2
... Microsphere/Microarray Stabilizer is a is a bovine ... This product is an aqueous solution that ... (phosphate buffered saline), pH 6.6 - 7.2. ... 0.02% methylisothiazolone and 0.02% bromonitrodioxane as a ...
... aqueous-based mounting medium designed for the ... is especially recommended when using tracers ... It can also be used with ... (FITC), Rhodamine (TMRITC) and Texas Red. ...
...
... Product Rabbit polyclonal to JNK1 (phospho ... mapping to an internal domain containing phosphorylated T183/Y185. ... Mouse and Rat. Not yet tested in other ... of several subgroups, including the ERK, JNK, and ...
Biology Products: